Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Antimicrob Agents Chemother ; 50(8): 2789-96, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16870773

ABSTRACT

The objective was to improve efficacy of antisense phosphorodiamidate morpholino oligomers (PMOs) by improving their uptake into bacterial cells. Four different bacterium-permeating peptides, RFFRFFRFFXB, RTRTRFLRRTXB, RXXRXXRXXB, and KFFKFFKFFKXB (X is 6-aminohexanoic acid and B is beta-alanine), were separately coupled to two different PMOs that are complementary to regions near the start codons of a luciferase reporter gene (luc) and a gene required for viability (acpP). Luc peptide-PMOs targeted to luc inhibited luciferase activity 23 to 80% in growing cultures of Escherichia coli. In cell-free translation reactions, Luc RTRTRFLRRTXB-PMO inhibited luciferase synthesis significantly more than the other Luc peptide-PMOs or the Luc PMO not coupled to peptide. AcpP peptide-PMOs targeted to acpP inhibited growth of E. coli or Salmonella enterica serovar Typhimurium to various extents, depending on the strain. The concentrations of AcpP RFFRFFRFFXB-PMO, AcpP RTRTRFLRRTXB-PMO, AcpP KFFKFFKFFKXB-PMO, and ampicillin that reduced CFU/ml by 50% after 8 h of growth (50% inhibitory concentration [IC(50)]) were 3.6, 10.8, 9.5, and 7.5 microM, respectively, in E. coli W3110. Sequence-specific effects of AcpP peptide-PMOs were shown by rescuing growth of a merodiploid strain that expressed acpP with silent mutations in the region targeted by AcpP peptide-PMO. In Caco-2 cultures infected with enteropathogenic E. coli (EPEC), 10 microM AcpP RTRTRFLRRTXB-PMO or AcpP RFFRFFRFFXB-PMO essentially cleared the infection. The IC(50) of either AcpP RTRTRFLRRTXB-PMO or AcpP RFFRFFRFFXB-PMO in EPEC-infected Caco-2 culture was 3 microM. In summary, RFFRFFRFFXB, RTRTRFLRRTXB, or KFFKFFKFFXB, when covalently bonded to PMO, significantly increased inhibition of expression of targeted genes compared to PMOs without attached peptide.


Subject(s)
Bacterial Proteins/antagonists & inhibitors , Escherichia coli Proteins/antagonists & inhibitors , Escherichia coli/drug effects , Morpholines/pharmacology , Peptides/antagonists & inhibitors , Salmonella typhimurium/drug effects , Bacterial Proteins/genetics , Caco-2 Cells , Cell Survival/drug effects , Colony Count, Microbial , Dose-Response Relationship, Drug , Escherichia coli/genetics , Escherichia coli/growth & development , Escherichia coli/pathogenicity , Escherichia coli Infections/drug therapy , Escherichia coli Proteins/genetics , Genes, Bacterial , Genes, Reporter , Humans , In Vitro Techniques , Inhibitory Concentration 50 , Kinetics , Luciferases/antagonists & inhibitors , Morpholines/chemical synthesis , Morpholines/chemistry , Morpholinos , Mutation , Peptides/genetics , Salmonella typhimurium/classification , Salmonella typhimurium/genetics , Salmonella typhimurium/growth & development , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL
...